Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 3Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1Thymoma 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1SCLC, Extensive Stage 1Resectable Esophageal Cancer 1Rectal Neoplasms 1Pathologic Complete Response 1Oropharyngeal Neoplasms 1Neoplasms 1NSCLC 1Mouth Neoplasms 1Lung Neoplasms 1Esophageal Squamous Cell Carcinoma 1Efficacy and Safety of Short-course Radiotherapy in Total Neoadjuvant Therapy Combined With Enlonstobart for pMMR Locally Advanced Rectal Cancer 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Gemcitabine 8Cystectomy 6Cisplatin 5Mitomycin 3toripalimab 2tislelizumab 2disitamab vedotin 2Radiotherapy 2Radiosurgery 2Magnetic Resonance Spectroscopy 2Drug Therapy 2zimberelimab 1trilaciclib 1sacituzumab govitecan 1nimotuzumab 1entinostat 1durvalumab 1cemiplimab 1Transurethral Resection of Bladder 1Therapeutics 1Synapsins 1Saline Solution 1Radiotherapy, Intensity-Modulated 1RC48 antibody 1Olive Oil 1Niacinamide 1Niacin 1Music Therapy 1Liquid Biopsy 1Immunonutrition Diet 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Urinary Bladder Neoplasms × Chemoradiotherapy × Clear all
NCT07008833 2026-02-12

REDEMPTED

Brazilian Clinical Research Institute

Phase NA Not yet recruiting
336 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡